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Asthma incidence and prevalence are higher in obese individuals. A potential mechanistic basis for this relationship is pleiotropy. We
hypothesized that signiﬁcant linkage and candidate-gene association would be found for body mass index (BMI) in a population ascer-
tained on asthma affection status. Linkage analysis for BMI was performed on 657 subjects in eight Costa Rican families enrolled in
a study of asthma. Family-based association studies were conducted for BMI with SNPs within a positional candidate gene, PRKCA.
SNPs within PRKCA were also tested for association with asthma. Association studies were conducted in 415 Costa Rican parent-child
trios and 493 trios participating in the Childhood Asthma Management Program (CAMP). Although only modest evidence of linkage
for BMI was obtained for the whole cohort, signiﬁcant linkage was noted for BMI in females on chromosome 17q (peak LOD ¼
3.39). Four SNPs in a candidate gene in this region (PRKCA) had unadjusted association p values < 0.05 for BMI in both cohorts,
with the joint p value for two SNPs remaining signiﬁcant after adjustment for multiple comparisons (rs228883 and rs1005651, joint
p values¼ 9.53 105 and 5.63 105). Similarly, eight SNPs had unadjusted association p values< 0.05 for asthma in both populations,
with one SNP remaining signiﬁcant after adjustment for multiple comparisons (rs11079657, joint p value ¼ 2.6 3 105). PRKCA is
a pleiotropic locus that is associated with both BMI and asthma and that has been identiﬁed via linkage analysis of BMI in a population
ascertained on asthma.Introduction
Asthma affects an estimated 300million individuals world-
wide.1 A number of large cross-sectional2–6 and prospec-
tive7–10 epidemiologic studies have independently noted
an elevated risk of asthma in association with increasing
body mass index (BMI). This association has often been
reported only8,9 or more strongly in females.2,4,7 For
instance, the population attributable risk of asthma result-
ing from obesity has been estimated to be as high as 28%
in postpubertal females11 but to be not signiﬁcant in post-
pubertal males.
A variety of mechanisms have been proposed to link
obesity with asthma. We have previously postulated that
common genetic pathways may contribute, given that
both obesity and asthma are complex traits with signiﬁ-
cant heritability and previous studies have shown linkage
to both obesity and asthma for the same genomic
regions.12 Although twin studies have veriﬁed that a signif-
icant amount of the covariation between obesity and
asthma is caused by shared genetic risk factors for both
conditions,13,14 to our knowledge, no gene has been asso-
ciated with both obesity and asthma.
In this study, we report the results of a genome-wide
linkage analysis of BMI in eight extended families of
Costa Rican childrenwith asthma. Because of knownmodi-
ﬁcationof the effect ofBMIonasthmaby sex and thepoten-
tial for sex-speciﬁc genetic effects on both asthma and
obesity,15–18 we report both overall and sex-stratiﬁed
linkage results.We show signiﬁcant linkage to BMI on chro-mosome 17q24 in females. Although multiple interesting
candidate genes are locatedwithin this linkagepeak, several
of these, including somatostatin receptor 2 (SSTR2, [MIM
182452]), galanin receptor 2 (GALR2,[MIM 603691]), and
growth factor receptor-bound protein 2 (GRB2, [MIM
108355]) have been previously tested for association with
obesity phenotypes, with negative results.19 In addition,
a knockout mouse model of the regulatory II beta isoform
subunit in protein kinase C a (PRKCA [MIM 176960]),
results in almost no white adipose tissue.20 We therefore
chose to conduct an association study for PRKCA, a candi-
date gene located within the linkage region of interest. We
ﬁrst demonstrate an association between single-nucleotide
polymorphisms (SNPs) in PRKCA and BMI in two indepen-
dent family-based cohorts of children with asthma. Given
the relationship between asthma and obesity, we also
present evidence for association between PRKCA SNPs and
asthma affection status in these populations.
Subjects and Methods
Study Populations
Costa Rica
Eight families of Costa Rican children ascertained on asthma affec-
tion status were recruited as previously described.21 In brief, in
addition to asthma affection status, inclusion criteria for the eight
probands included ageR 6 years but% 14 years,R 1 sibling with
physician-diagnosed asthma, increased airway responsiveness
(a dose ofmethacholine causing a 20% reduction in FEV1 [PD20]%
8.58 mmol of methacholine) and R 6 great-grandparents born in
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The family-based association study of PRKCA and BMI was con-
ducted in an independent set of 415 Costa Rican children with
asthma and their parents (parent-child trios). Index children in
the trios were recruited on the basis of age (6 to 14 years), asthma
(deﬁned as physician-diagnosed asthma and either at least two
respiratory symptoms or asthma attacks in the previous year)
and a high probability of having R 6 great-grandparents born in
the Central Valley of Costa Rica.
All study participants (with the exception of parents in trios,
who only provided a blood sample) completed a protocol that
included a questionnaire and collection of blood samples for
DNA extraction and measurements of height and weight. Height
was measured with a stadiometer to the nearest half inch. Weight
was measured with a professional scale (Tanita Corp., Arlington
Heights, IL).
Written consent was obtained from adults. Written parental
consent was obtained for children, for whom written assent was
also obtained. The study was approved by the Institutional Review
Boards of the Hospital Nacional de Nin˜os (San Jose´, Costa Rica)
and Brigham and Women’s Hospital (Boston, MA).
The Childhood Asthma Management Program
The Childhood Asthma Management Program (CAMP) was a clin-
ical trial evaluating the effects of anti-inﬂammatory medications
in children with mild to moderate asthma over a period of
4-6 years.22,23 Inclusion criteria included doctor’s diagnosis of
asthma in conjunction with presence of asthma symptoms and/
or low peak ﬂow readings during a run-in when taking albuterol,
as well as evidence of increased airway responsiveness (PC20 %
12.5 mg/mL of methacholine). This analysis was restricted to
493 non-Hispanic white participants and their parents because
of the small sample size of other ethnic groups. CAMP was
approved by the Institutional Review Boards of the Brigham and
Women’s Hospital and the other CAMP study centers.
Phenotypes
Primary Outcome—BMI
For all subjects, BMI was calculated as kg/m2.
Secondary Outcome—Asthma
To enhance comparability of the asthma phenotype among Costa
Rican children in trios with that used in CAMP, we deﬁned asthma
as (1) physician-diagnosed asthma and either two respiratory
symptoms or asthma attacks in the prior year and (2) increased
airway responsiveness (PD20 % 16.81 mmol of methacholine) or
(for children unable to undergo methacholine challenge testing)
increased bronchodilator response (improvement in baseline
FEV1 of 12% or greater [at least 200 ml] after albuterol administra-
tion).24 In CAMP, all probands were classiﬁed as having asthma.
Genotyping
The Genome Quebec Innovation Centre performed genome-wide
microsatellite genotyping in 671 individuals from the eight
extended pedigrees in CR (Costa Rica) by using Applied Biosys-
tems (AB) 3700 and 3730 analyzers with DNA that was extracted
from blood samples with Puregene Kits (Gentra Systems). A total
of 380 autosomal short-tandem repeat (STR) markers with an
average spacing of 8.2 cM were genotyped.
RELPAIR was used for determining pedigree relationships on the
basis of the genome scan marker data.25,26 Mendelian inconsis-
tencies at individual markers were resolved with PEDCHECK.27
Pedigree genotype inconsistencies were observed on average
<0.5% per STR.88 The American Journal of Human Genetics 85, 87–96, July 10, 20Additional SNP genotyping was performed in the 415 Costa
Rican trios with Illumina Golden gate technology. We initially
selected 39 SNPs from the PRKCA gene by using the following
criteria: reported minor allele frequency (MAF) R 10%, validated
in Golden Gate, and location within the gene every ~10 kb. After
the initial analysis using these 39 SNPs, we extended coverage of
PRKCA by using data from European Americans (CEU) in the Inter-
national HapMap project25 and applying a linkage disequilibrium
(LD)-tagging algorithm26 (MAF R 10% and r2 > 0.8) to capture
common variation in PRKCA and its 50 kb ﬂanks. We used the
‘‘force include’’ option to include the 39 previously genotyped
SNPs, when possible. This process led to selection of an additional
137 SNPs in PRKCA, which were successfully genotyped in Costa
Rican trios with the SEQUENOM iPLEX platform27 (Sequenom,
San Diego, CA). Replication genotyping was performed on the
INITIAL 39 SNPs in 493 CAMP families with the Illumina
Golden-Gate genotyping assay (Illumina, San Diego, CA);28 the
remaining LD-tag replication SNPs were genotyped in 400
CAMP families as part of a larger experiment with the Illumina
Inﬁnium HumanHap550 genotyping chip (Illumina, San Diego,
CA).29 In both Costa Rica and CAMP, duplicate genotyping was
performed on ~5% of the samples. Genotype quality control was
assessed by <1% discordances, <5 Mendelian inconsistencies,
and genotype completion rates of >98.5% for all loci.
Statistical Analyses
Linkage Analysis
Multipoint linkage analysis was conducted with the variance
components approach implemented in the Sequential Oligogenic
Linkage Analysis Routines (SOLAR) program (version 2.1.5).30
SOLAR uses identity-by-descent sharing to segment the observed
phenotypic variance into genetic and nongenetic components.
The multipoint identity-by-descent matrices were estimated with
the Loki program.31
Because of potential sexual dimorphism in BMI, a sex-stratiﬁed
analysis was conducted in addition to an analysis of the overall
sample. The variance components models in SOLARwere adjusted
for age, age squared, and sex (in the overall cohort only). Covari-
ates with a p value< 0.05 were retained in the ﬁnalmodel. Because
of the nonnormality of the BMI distribution (resulting in residual
kurtosis estimates ranging from 1.0–2.3), robust LOD scores were
calculated.32 We obtained the robust LOD scores by applying an
adjustment factor to the observed LOD scores. In brief, to calculate
the adjustment factor, we generated an empirical distribution
(based on 10,000 simulations) of LOD scores under the null
hypothesis, by using simulated, fully informative markers that
are unlinked to the trait. The adjustment factor is the coefﬁcient
obtained from a regression of the simulation-based LOD scores
on the LOD scores that would be expected under a normally
distributed trait. The LOD adjustment factors were 0.99 in the
overall group, 0.59 in males, and 1.18 in females. Robust LOD
scoresR 3.3 were considered signiﬁcant.33
Association Analysis
Family-based association tests (FBATs) of BMI and asthma were
conducted in the Costa Rican and CAMP families with PBAT34
(version 3.5), in both the overall set of families and sex-stratiﬁed
groups, under additive, dominant, and recessive genetic models.
The PBAT approach provides a general framework that can accom-
modate family-based analyses with missing parental genotypes,
additional siblings, quantitative phenotypes, extended pedigrees,
and multivariate traits.34–38 The quantitative BMI analysis was
adjusted for age, age-squared, and sex. For quantitative traits,09
evidence for association is suggested when the transmission of an
allele is strongly correlatedwith phenotypic values. The analysis of
asthma did not adjust for any covariates; previous studies have
shown that the inclusion of covariates in a family-based analysis
of a binary trait may reduce power.39 In an analysis of trios in
which all offspring are affected (i.e., asthma), without adjustment
for covariates, under an additive model, the family-based associa-
tion test is equivalent to the transmission disequilibrium test
(TDT).40 Evidence of association is suggested when an allele is
systematically over- or undertransmitted more than would be ex-
pected (conditioning on parental mating types and assuming
Mendelian transmission) by chance alone.
Although longitudinal data are available for CAMP subjects
(with a maximum of 14 measurements over a 4 year time period),
BMI was measured at only one time point in the Costa Rican fami-
lies. Thus, the randomization visit (RZ) was selected as the time
point for the primary replication analysis in CAMP. This visit
was selected so that the number of missing subjects and the
impact of any asthma treatment intervention on BMI could be
minimized. A secondary, multivariate, longitudinal analysis of
BMI was also conducted in the CAMP subjects, with a popula-
Table 1. Baseline Characteristics of Members of Extended
Pedigrees of Costa Rican Children with Asthma
Family N
Gender,
Female (%)
Mean
BMI (SD)
Mean
Age (SD)
Asthma
(%)
1 (5001) 34 16 (47.1) 23.4 (4.5) 34.9 (19.3) 12 (35.3)
2 (5002) 20 11 (55.0) 24.9 (4.7) 33.7 (19.3) 8 (40.0)
3 (5003) 233 135 (57.9) 23.8 (5.6) 27.9 (17.1) 59 (25.3)
4 (5004) 102 61 (59.8) 24.8 (5.7) 32.0 (17.9) 17 (16.7)
5 (5005) 8 7 (87.5) 27.8 (5.6) 36.0 (20.5) 2 (25.0)
6 (5006) 107 60 (56.1) 23.2 (5.4) 29.1 (17.1) 8 (7.5)
7 (5007) 23 10 (43.5) 24.8 (4.9) 32.2 (19.0) 5 (21.7)
8 (5008) 130 56 (43.1) 22.9 (5.3) 28.1 (18.9) 24 (18.5)
Total 657 301 (45.8) 23.8 (5.5) 29.6 (17.9) 135 (20.6)Thtion-based approach.We conducted the population-based analysis
in SAS (version 9.1) by using mixed models, with ﬁxed effects for
the SNP, subject age at baseline, age at baseline squared, gender,
and time under study. Random intercepts and slopes were
modeled for each subject.
In assessing joint evidence for association, p values were
combined across study populations with Fisher’s combined prob-
ability method.41 In combining the p values, all hypothesis tests
in the replication population had one-sided alternatives (based
on the direction of the association in the testing population), so
that combined test statistics from association tests in opposite
directions would not produce inappropriately small p values. For
comparison, p values reﬂecting two-sided alternatives in both pop-
ulations were also calculated. After calculating joint p values, the
results were compared against an overall signiﬁcance threshold
that was Bonferroni-corrected for the overall number of compari-
sons conducted per phenotype (528 comparisons: 176 SNP 3 3
genetic models). For both the BMI and asthma analyses, a SNP
with a Bonferroni adjusted p value < 9.5 3 105 (0.05/528) was
considered signiﬁcant.
Results
Characteristics of Extended Families Contributing
to Linkage Analysis
Of the 667 members of the extended pedigrees of Costa
Rican children with asthma, 657 subjects had a measured
BMI and were thus included in the multipoint linkage
analysis.30 Table 1 shows the characteristics of themembers
included in the linkage analysis. There was variability
among participating families with regard to number of
members, sex,BMI, andpercentageof subjectswithasthma.
Genome-wide Linkage Analysis of BMI
Figure 1 displays the main results of the genome-wide
linkage analysis of BMI in extended Costa Rican families.
There was only modest evidence of linkage for BMI for
the entire cohort (peak robust LOD ¼ 1.67) and littleFigure 1. Genome-wide Linkage of Body
Mass Index in 657 Costa Rican Subjects
from Eight Families
The families were ascertained via an asth-
matic proband. Signiﬁcant linkage is noted
for BMI in females on chromosome 17q,
with a peak LOD score of 3.39. The inset
demonstrates the approximate location of
PRKCA within the linkage peak.e American Journal of Human Genetics 85, 87–96, July 10, 2009 89
evidence for linkage to BMI in males in the sex-stratiﬁed
analysis (peak robust LOD ¼ 1.16). However, there was
signiﬁcant linkage to BMI in females on chromosome 17,
with a peak robust LOD score of 3.39, as well as modest
evidence for linkage to BMI in two other regions [chromo-
some 3 (1.48); chromosome 17 (1.44)]. The 1.5 LOD unit
support interval for the linkage peak on chromosome 17
fully encompasses chromosome17q23.2-q25.1, the loca-
tion of the PRKCA gene (Figure 2). Thus, wemoved forward
with association testing in the PRKCA region.
Characteristics of the Populations Contributing
to Association Analyses
Table 2 shows the characteristics of the probands in the
populations that were analyzed for association between
SNPs in PRKCA and BMI. After excluding subjects missing
BMI data, the primary test population for the BMI analysis
included 415 parent-child trios participating in a study of
the genetics of asthma in Costa Rica. Of the 415 Costa
Rican probands, 311 (~75%) had asthma with either
increased airway responsiveness or bronchodilator respon-
siveness (31 had missing data and 73 did not meet criteria
Figure 2. Distribution of p Values from
Family-Based Association Tests of Body
Mass Index in the Costa Rican and CAMP
Cohorts
The highlighted region contains four
SNPs signiﬁcantly associated in both
cohorts.
Table 2. Baseline Characteristics of Children in Nuclear Families
in Costa Rica and CAMP
Characteristic Costa Rica CAMP p Valuea
n 415 493 NA
Age in years, mean (SD) 9.1 (1.8) 8.8 (2.1) 0.01
Gender, female (%) 158 (38.1) 191 (38.7) 0.89
BMI, mean (SD) 17.8 (3.4) 17.8 (3.1) 0.79
Prebronchodilator FEV1%
predicted, mean (SD)
99.8 (15.9) 94.0 (13.8) 1.5 3 108
a This column reflects the p value from either a chi-square test of indepen-
dence for binary traits or student’s t test for continuous traits.
for stringent asthma) and were thus
included in the analysis of asthma.
After removing subjects missing BMI
measurements, the replication popu-
lation comprised 457 white families
with 493 offspring participating in
the CAMP clinical trial. Overall, the
groups were relatively balanced with
respect to gender and BMI, but there
were signiﬁcant differences in the
mean age (9.1 versus 8.8 years, p ¼
0.01) and percent predicted pre-bron-
chodilator FEV1 (99.8 versus 94.0, p ¼ 1.5 3 108) of the
participants in CAMP and Costa Rica.
Association Studies of PRKCA and BMI
Family-Based Analysis in Costa Rica and CAMP
In the analysis of the Costa Rica population, we initially
tested 39 SNPs in PRKCA for association with BMI in the
Costa Rica cohort by using FBATs. Of these, four SNPs
(rs228883, rs1005651, rs228875, and rs2244497) were
signiﬁcantly associated with BMI under a recessive genetic
model in the overall group, with (unadjusted) p values
ranging from 0.016 to 0.001. For all four SNPs, transmis-
sion of two copies of the minor allele was associated with
increased BMI. On the basis of the strong evidence of asso-
ciation, these four SNPs were tested in the CAMP cohort.
All four SNPs replicated in CAMP under a recessive genetic
model and demonstrated association in the same direc-
tion, with p values of similar magnitude (one sided p
values ranged from 0.018 to 0.004). The results from
both the Costa Rica and CAMP populations are presented
in Table 3. In this table, genetic effect sizes are also pre-
sented. Across all four SNPs, the observed increase in BMI
ranges from 1.21 to 2.45 across the two populations.
The joint p value (from Fisher’s combined probability
method41) was compared against a signiﬁcance threshold
(9.5 3 105) that was Bonferroni corrected for the overall
number of comparisons (528) conducted in the primary
analysis of the BMI phenotype. Although this association
with BMI was observed among the 39 SNPs initially
genotyped, we adjusted for the ﬁnal number of compari-
sons conducted for this phenotype, thus including the
additional 137 LD-tagging SNPs. Of the four SNPs, two
(rs228883 and rs1005651) were signiﬁcantly associated
with BMI after correction for multiple comparisons,
with joint p values of 5.6 3 105 and 9.5 3 105, respec-
tively. However, given the consistency in association and90 The American Journal of Human Genetics 85, 87–96, July 10, 2009
Table 3. Evidence for Association of PRKCA with BMI in Costa Rica and CAMP
Allele
Frequency
Number of Informative
Familiesb (number of
offspring with 0/1
recoded genotype) Effect Sizec
Marker
Location
(BP)a
Minor
Allele CR CAMP CR CAMP CR CAMP
CR
p Valued,e
CAMP Replication
p Valued,e
(two-sided)
Joint p Valuef
(CR, CAMP
two-sided)
rs228883 61874457 T 0.27 0.33 91 (67/24) 110 (80/39) 2.45 1.60 þ0.0011 þ0.0038 (þ0.0076) 5.6 3 105**
(1.0 3 104)
rs1005651 61868473 C 0.26 0.33 83 (60/23) 113 (83/39) 2.27 1.60 þ0.0019 þ0.0039 (þ0.0077) 9.5 3 105**
(1.8 3 104)
rs228875 61924337 A 0.29 0.35 101 (70/31) 129 (92/46) 1.71 1.22 þ0.0109 þ0.0182 (þ0.0364) 0.0019
(0.0035)
rs2244497 61931405 C 0.31 0.36 120 (86/34) 136 (98/47) 1.69 1.21 þ0.0160 þ0.0171 (þ0.0341) 0.0025
(0.0046)
a SNP positions from dbSNP build 129. PRKCA is located on chr17:61,729,388-62,237,324, with the ATG start site located at position 61,729,432,(hg18).
b Number of informative families for the FBAT statistic under a recessive model (i.e., both parents had at least one copy of the minor allele and at least one parent
was heterozygous). The number of offspring in CAMP families may be greater than the number of informative families, given that some families had more than one
offspring.
c The genetic effect size is obtained from the following model: BMI~ (x  Ex) þ ageþ age2 þ sex, where x reflects the coding of the minor allele of the SNP under
the recessive model (i.e., 0 for 0/1 copies, 1 for 2 copies), and Ex is the expected transmission under the null hypothesis of no linkage/association.
d From the FBAT statistic, adjusting for age, age2, and sex. In Costa Rica, p values reflect a two-sided alternative hypothesis, whereas the replication p values in
CAMP are one sided. The p value in parentheses under the CAMP replication reflects a two-sided alternative hypothesis. CAMP and CR p values are unadjusted for
multiple comparisons.
e A plus sign (þ) indicates that transmission of two copies of the minor allele (in comparison to zero or one copy) is associated with an increase in BMI.
f The joint p value reflects the combination of a two-sided alternative hypothesis in CR and a one-sided alternative hypothesis in CAMP. The p values in parentheses
are the combination of a two-sided alternative hypothesis in both CR and CAMP. Double asterisks (**) indicate that the joint p value was significant after Bonferroni
correction for the number of comparisons conducted (528, 176 SNP 3 3 genetic models) in the Costa Rican cohort. The threshold for significance is 9.5 3 105
(0.05/528).3signiﬁcant (unadjusted) p values in each cohort, we
considered SNPs rs228875 and rs224497 to be suggestive
of association and included them as markers of interest
in the longitudinal analysis in CAMP, our replication
population. It also should be noted that if p values from
two-sided alternative hypotheses were used for both Costa
Rica and CAMP (instead of two-sided in Costa Rica and
one-sided in CAMP) when calculating the joint test
statistic p values (given in parentheses in Table 3), the
joint p values (1.0 3 104 and 1.8 3 104 for rs228875
and rs224497, respectively) would not have met the signif-
icance criteria after our conservative adjustment for
multiple comparisons, which ignored linkage disequilib-
rium in this region and incorporated adjustment for
testing under multiple genetic models in both the initial
and replication population.
Asnoted above, after observing the initial results for these
four SNPs, the additional 137 LD-tag SNPs inCosta Rica and
the CAMP families were tested for association. None of the
additional tests demonstrated convincing evidence of asso-
ciation (Figure 2). The highlighted region contains the four
SNPs thatwere signiﬁcant in both theCosta Rica andCAMP
populations. Additionally, in the gender-stratiﬁed analysis,
females did not demonstrate stronger evidence of associa-
tion than males (data not shown).
Longitudinal Analysis of BMI in CAMP
To extract the most information from the CAMP study, we
also conducted a population-based longitudinal analysis ofThBMI for the four SNPs of interest. Each marker was
analyzed separately. All four SNPs were signiﬁcant predic-
tors (with unadjusted p values between 0.0048 and
0.0007) of BMI in the mixed linear models and demon-
strated a consistent increase in mean BMI over time in
probands with two copies of the minor allele. The coefﬁ-
cients for the markers ranged from 1.29 (rs1005651) to
0.99 (rs2244497), reﬂecting an overall mean BMI increase
of 0.99 to 1.29 in subjects with two copies of the minor
allele. An exemplar proﬁle plot (rs228883) is shown in
Figure 3. At each follow-up visit, the mean BMI of
probands with two copies of the minor allele is approxi-
mately 1.2–1.8 units higher than probands with one or
two copies of the wild-type allele.
Association of PRKCA SNPs and Asthma
Family-Based Association Analysis in Costa Rica and CAMP
Given that both our primary test and replication popula-
tions were ascertained on asthma, we tested for association
between the genotyped PRKCA SNPs and asthma affection
status in both the CAMP and Costa populations. Two
SNPs, rs732191 and rs9895580, demonstrated association
at p < 0.05 in both populations under a recessive genetic
model (Table 4). These SNPs are within 10 Kb of each other
with an r2 ¼ 0.99.
Additional testing of the 137 LD-tag SNPs in the Costa
Rica andCAMPcohorts revealed that the asthma-associated
region extended far beyond the two originally identiﬁed
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identiﬁed SNPs, there were an additional 13 SNPs with
unadjusted p values < 0.05 in Costa Rica; eight of these
SNPs also had (unadjusted) one-sided p values < 0.025 in
the CAMP population (Table 4). These results included the
two markers initially identiﬁed, rs732191 and rs9895580.
As done for the BMI analysis, the p values displayed for
CAMP are one-sided p values. The direction of the associa-
tion was identical across CAMP and Costa Rica (shown in
front of p values in Table 4 as a plus sign for overtrans-
mission of the minor allele and as a negative sign for
Figure 3. PRKCA SNP rs22883 Influences
BMI Both at Baseline and longitudinally
in the CAMP population
At each time point, subjects homozygous
for the mutant allele have at least a one
unit increase in their BMI. The dashed
lines reﬂect point-wise 95% conﬁdence
intervals.
undertransmission of the minor
allele). For the CAMP population,
association p values reﬂecting both
one-sided and two-sided (in paren-
theses) alternative hypotheses are
given. The transmitted-to-
untransmitted ratios of the minor
allele, presented in Table S1 available
online, also demonstrate the consis-
tency of the direction of the association across the two pop-
ulations.
Although exploration of the association between BMI
and SNPs in PRKCA was considered our primary analysis,
we also considered multiple comparisons adjustment
when calculating the joint p value (Table 4) for asthma.
There were 176 SNP in total analyzed for asthma (39 þ
137), tested under three genetic models; thus we consid-
ered any joint p value < 9.53 105 (0.05/(1763 3)) signif-
icant at the alpha ¼ 0.05 level. One SNP, rs11079657,Table 4. Evidence for Association of PRKCA with Asthma in Costa Rica and CAMP
Allele Frequency
Number of Informative
Familiesb (number of offspring
with 0/1 recoded genotype)
Marker
Location
(BP)a
Minor
Allele CR CAMP CR CAMP
Costa Rica
p Valuec,d
CAMP Replication
p Valuec,d
(two-sided)
Joint p Valuee
(CR, CAMP
two-sided)
rs732191 61779673 G 0.46 0.35 168 (117/51) 141 113/43 0.0194 0.0214 (0.0428) 0.0036 (0.0067)
rs9895580 61789701 C 0.47 0.35 168 (117/51) 141 114/43 0.0171 0.0160 (0.0320) 0.0025 (0.0047)
rs4411531 61793662 A 0.29 0.12 88 (70/18) 25 (24/1) 0.0058 0.0058 (0.0117) 0.0004 (0.0007)
rs8080771 61824330 G 0.46 0.35 164 (116/48) 108 (90/29) 0.0161 0.0070 (0.0140) 0.0011 (0.0021)
rs11652956 61839798 G 0.29 0.12 83 (65/18) 23 (22/1) 0.0101 0.0111 (0.0222) 0.0011 (0.0021)
rs7221968 61848731 C 0.27 0.11 79 (63/16) 18 (17/1) 0.0122 0.0216 (0.0432) 0.0024 (0.0045)
rs7405806 61862056 A 0.49 0.31 164 (109/55) 90 (77/20) 0.0309 0.0009 (0.0018) 0.0003 (0.0006)
rs11079657 61862528 A 0.38 0.23 129 (94/35) 60 (56/8) 0.0092 0.0002 (0.0004) 2.6 3 105**
(5.0 3 105**)
a SNP positions from dbSNP build 129. PRKCA is located on chr17:61,729,388-62,237,324, with the ATG start site located at position 61,729,432,(hg18).
b Number of informative families for the FBAT statistic under a recessive model (i.e., both parents had at least one copy of the minor allele and at least one parent
was heterozygous). The number of offspring in CAMP families may be greater than the number of informative families, given that some families had more than 1
offspring.
c From the FBAT statistic. The Costa Rica p values reflect a two-sided alternative hypothesis, whereas the replication p values in CAMP are one sided. The p value in
parentheses under the CAMP replication reflects a two-sided alternative hypothesis. CR and CAMP p values are unadjusted for multiple comparisons.
d A minus sign () indicates that the minor allele is undertransmitted to subjects with asthma.
e The joint p value reflects the combination of a two-sided alternative hypothesis in CR and a one-sided alternative hypothesis in CAMP. The p values in paren-
theses are the combination of a two-sided alternative hypothesis in both CR and CAMP. Double asterisks (**) indicate that the joint p value was significant after
Bonferroni correction for the number of comparisons conducted (528, 176 SNP 3 3 genetic models) in the Costa Rican cohort. The threshold for significance is
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demonstrated signiﬁcant association after this correction,
with a joint p value of 2.63 105. This SNP was also signif-
icant (5.0 3 105) when applying a two-sided alternative
hypothesis (and p value) to the results in the CAMP popu-
lation. None of the other eight SNPs met the criteria for
adjusted signiﬁcance, although the consistency and
strength of association in each population is suggestive
of an association.
Discussion
In the genetic evaluation of BMI in families ascertained via
asthma, we have sequentially identiﬁed a region on chro-
mosome 17q that was signiﬁcantly linked to BMI, investi-
gated, and replicated the association of the positional
candidate gene PRKCAwith BMI, and conﬁrmed the pleio-
tropic nature of PRKCA via its association with asthma in
two populations. The description of signiﬁcant linkage
and replicated associations with a positional candidate is
noteworthy.
Among female members of large Costa Rican families,
there was signiﬁcant evidence of linkage to BMI on
chromosome 17q22-q24, with a peak LOD score of 3.39.
This genomic region has been previously linked to
obesity-related phenotypes in several other studies,19,42–44
including a replicated linkage scan in individuals of
Hispanic (predominantly Mexican) descent.19,42 Although
the other scans in this region were not sex stratiﬁed, the
ﬁnding of a linkage primarily within the female members
of our pedigrees may be related to the ascertainment
scheme, given that the genetic liability to obesity in asthma
may be signiﬁcantly greater in females.13 Our linkage
results for BMI are theﬁrst reported in families of asthmatics
andprovide increased conﬁdence that a geneor genes in the
17q22-q24 region truly inﬂuences BMI. This region is adja-
cent to a previously identiﬁed area of possible linkage to
asthma in the same Costa Rican pedigrees.21
We report an association of SNPs within the protein
kinase-Ca gene (PRKCA) with BMI in two populations. As
longitudinal proﬁling demonstrates, the effects of this
gene on BMI do not appear conﬁned to early childhood
(Figure 3). PRKCA was investigated because of its location
centrally within our linkage peak for BMI on chromosome
17 (PRKCA maps to 17q22-q23.2), its biologic plausibility
as an obesity gene, and our concurrent interest in the
gene in asthma pathogenesis and drug treatment response.
Protein kinase-C represents a family of closely related
serine and threonine protein kinases that regulate a wide
variety of biological events within the cell.45 Protein
kinase-C a is felt to be the most ubiquitously expressed
protein kinase C and has been widely investigated for its
roles in cellular proliferation and differentiation; cell cycle
regulation; cell adhesion, survival, and apoptosis; and
cellular transformation.46 Although PRKCA has not previ-
ously been associated with BMI or obesity in humans,
Zucker obese (fa/fa) rats have decreased expression of
protein kinase-Ca compared to Zucker lean control (fa/)Thanimals.46 Moreover, protein kinase-C a is a negative feed-
back inhibitor of adipocyte differentiation and insulin
signaling,47–53 both of which are crucial determinants of
human obesity. Therefore, it is entirely plausible that
PRKCA genetic variation, such as that observed in our
cohorts, can lead to decreased protein kinase-Ca expres-
sion, thereby leading to increased insulin-related fat depo-
sition, adipocyte differentiation, and subsequent increases
in body mass.
Twin studies have estimated that ~8% of the genetic
component of obesity is sharedwith asthma.13,14 However,
to our knowledge, no gene has previously been shown to be
associated with both obesity and asthma within the same
study populations. In addition to its association with BMI,
we also report the pleiotropic association of PRKCA with
asthma in two populations. As noted above, 17q has been
previously linked to asthma and asthma-related pheno-
types.21,54–58 Given the ubiquitous expression and diverse
cellular roles of protein kinase-Ca, it is not surprising
that expression of this gene has also been associated with
smooth muscle proliferation.59,60 Moreover, increased
protein kinase-Ca has also been demonstrated to sensitize
smooth muscle to contraction,61–64 leading to a postulated
therapeutic effect related to PRKCA inhibition in asthma.61
Additional evidence that PRKCAmay contribute to asthma
pathogenesishas been reported: increases inproteinkinase-
C amay induce nitric oxide induced airway inﬂammation
and mucous production,65 regulate matrix metalloprotei-
nase-9 associated with airway remodeling,66 and help
mediate leukotriene D4 signaling.66
Although we report signiﬁcant linkage to BMI in females
only, our association analyses did not reveal results speciﬁc
to females. The most likely explanation for this disparity is
that the association populations consisted of children,
whereas the linkage pedigrees consisted of mostly adults.
In cohort studies, the association between asthma and
obesity has been consistently reported as stronger in
adult females;2,4,7,11 the gender-speciﬁc relationship is
less convincing in children.5,6 Therefore, our genetic anal-
yses of BMI in populations ascertained on asthma affection
status may also be inﬂuenced in a sex-speciﬁc manner
according to age.
The issue of multiple testing must also be addressed
when attempting to identify associations within linked
regions.67 For both BMI and asthma, our ﬁndings were
considered statistically signiﬁcant if they were replicated
at the SNP level (for the same phenotype and in the
same direction) after Bonferroni correction for the number
of comparisons for each phenotype.
We note that PRKCA as a positional candidate gene is
associated with two distinct, but partially correlated,
phenotypes and therefore ascribe pleiotropy at the level of
the gene. However, we acknowledge that the SNPs associ-
ated with BMI differ from those associated with asthma.
We further acknowledge that, because the asthma associa-
tions within the gene occur with SNPs that lie just 50 of
the SNPs associated with BMI, it is not possible toe American Journal of Human Genetics 85, 87–96, July 10, 2009 93
distinguish a truly pleiotropic locus from that of two very
closely linked loci, given the currently available data. Addi-
tionally, although we have completely covered the PRKCA
gene for known common variants via LD tagging, each of
our signiﬁcant associations was with an intronic SNP.
Further work, including deep resequencing to identify
both common and rare variants that may help to explain
the linkage disequilibrium patterns and functional basis
for these associations, is clearly needed. Because protein
kinase C is well known to demonstrate cell-speciﬁc differ-
ences in expression,68,69 additional functional work could
be directed at determining whether the SNPs associated
with BMI and those associated with asthma could be in
linkage disequilibrium with a variant or variants that alter
PRKCA expression, each in a tissue-speciﬁc manner.
In conclusion, by exploring the genetic inﬂuences on
BMI through cohorts ascertained on asthma affection
status, we have conﬁrmed a locus on 17q inﬂuencing
BMI and identiﬁed the positional candidate gene, PRKCA,
as a gene associated with BMI in two populations. More-
over, we have also noted that PRKCA is a pleiotropic locus
associated with asthma susceptibility in addition to BMI.
The search for genetic factors inﬂuencing a given trait in
populations ascertained by way of a different but biologi-
cally related phenotypic characteristic may yield new
insights into identifying both positional and pleiotropic
loci.
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